INHIBRX INC's ticker is INBX and the CUSIP is 45720L107. A total of 103 filers reported holding INHIBRX INC in Q3 2022. The put-call ratio across all filers is 34.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $895,480 | -29.3% | 48,800 | 0.0% | 0.01% | -22.2% |
| Q2 2023 | $1,266,848 | +126.0% | 48,800 | +64.3% | 0.02% | +125.0% |
| Q1 2023 | $560,439 | -23.4% | 29,700 | 0.0% | 0.01% | -20.0% |
| Q4 2022 | $731,808 | -6.3% | 29,700 | -31.7% | 0.01% | -9.1% |
| Q3 2022 | $781,000 | -10.1% | 43,500 | -43.2% | 0.01% | -8.3% |
| Q2 2022 | $869,000 | -21.5% | 76,600 | +54.1% | 0.01% | -7.7% |
| Q1 2022 | $1,107,000 | -49.8% | 49,700 | -1.6% | 0.01% | -43.5% |
| Q4 2021 | $2,205,000 | – | 50,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 1,286,435 | $31,697,758 | 8.22% |
| Perceptive Advisors | 3,313,783 | $81,651,613 | 2.29% |
| RA Capital Management | 3,853,867 | $94,959,283 | 1.93% |
| Soleus Capital Management, L.P. | 478,302 | $11,785,361 | 1.69% |
| Sofinnova Investments, Inc. | 1,110,183 | $27,354,909 | 1.62% |
| Birchview Capital, LP | 70,448 | $1,736 | 1.23% |
| VIKING GLOBAL INVESTORS LP | 6,639,199 | $163,589,863 | 0.82% |
| Meridian Wealth Advisors, LLC | 122,315 | $3,013,842 | 0.78% |
| Gyon Technologies Capital Management, LP | 44,074 | $1,085,983 | 0.41% |
| ArrowMark Colorado Holdings LLC | 1,139,337 | $28,073,264 | 0.34% |